Earnings Feed
Start Free
LISATA THERAPEUTICS, INC.·4

Jan 13, 4:08 PM ET

Nisco James 4

4 · LISATA THERAPEUTICS, INC. · Filed Jan 13, 2026

Insider Transaction Report

Form 4
Period: 2026-01-09
LISATA THERAPEUTICS, INC.LSTA
Nisco James
SVP, Fin/Treas, Chief Actg Off
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-01-09+15,000→ 38,491 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−2,131$4,198→ 36,360 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−2,131$4,198→ 34,229 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−1,137$2,240→ 33,092 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−781$1,539→ 32,311 total
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-01-09+7,000→ 7,000 total
    Exercise: $1.97From: 2026-01-09Exp: 2036-01-09→ Common Stock (7,000 underlying)
Footnotes (4)
  • [F1]Represents 15,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
  • [F2]Includes 20,750 unvested restricted stock.
  • [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
  • [F4]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Signature
James Nisco|2026-01-13

Documents

1 file
  • 4
    wk-form4_1768338533.xmlPrimary

    FORM 4